Risedronate (Na)

Overview

Categories

Primary Characterstics

Indications

Back to top

Pharmacokinetics

Back to top

Contraindications

Back to top

Drug Interactions

Back to top

Side Effects

Back to top

Dosage

Risedronate (Na)'s dosage details are as follows:
Dose Single Dose Frequency Route Instructions

Adult Dosage

5 mg5 (5)24 hourlyPOFor treatment and prevention of Postmenopausal Osteoporosis:
5 mg5 (5)24 hourlyPOTreatment and Prevention of Glucocorticoid-Induced Osteoporosis:
30 mg30 (30)24 hourlyPOTreatment of Paget''s Disease :Retreatment may be considered (following post-treatment observation of at least 2 months) if relapse occurs, or if treatment fails to normalize serum alkaline phosphatase.
35 mg35 (35)As recommended.POTreatment to Increase Bone Mass in Men with Osteoporosis: Taken once a week.

Paedriatic Dosage (20kg)

No data regarding the Paedriatic dosage details of Risedronate (Na) is available.

Neonatal Dosage (3kg)

No data regarding the neonatal dosage details of Risedronate (Na) is available.

High Risk Groups

Back to top

Warning / Precautions

Back to top

Storage Conditions

Back to top

Interference in Pathology

Back to top

Brands / Trade Names of Risedronate (Na)

Back to top

Previous Drug Generic - Next Drug Generic